BME:NYE-BlackRock Health Sciences Trust (USD)

COMMON STOCK | Asset Management | NYE

Last Closing Price

USD 45.50

Change

-1.06 (-2.28)%

Market Cap

USD 0.59B

Volume

0.07M

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict


BlackRock Health Sciences Trust (BME) Stock Analysis:
Based on the BlackRock Health Sciences Trust stock forecasts from 0 analysts, the average analyst target price for BlackRock Health Sciences Trust is not available over the next 12 months. BlackRock Health Sciences Trust’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of BlackRock Health Sciences Trust is Bullish , which is based on 7 positive signals and 2 negative signals. At the last closing, BlackRock Health Sciences Trust’s stock price was USD 45.50. BlackRock Health Sciences Trust’s stock price has changed by -1.33 % over the past week, -2.62 % over the past month and -2.84 % over the last year.

About

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health s ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-12-02 )

Largest Industry Peers for Asset Management

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
BLK BlackRock Inc

+18.52 (+2.06%)

USD140.98B 23.94 16.06
BX The Blackstone Group Inc

+3.59 (+2.61%)

USD106.39B 18.89 N/A
BAM Brookfield Asset Management In..

+1.71 (+3.09%)

USD91.03B 25.99 9.17
PX Praxair, Inc

N/A

USD47.31B 34.30 N/A
BK The Bank of New York Mellon Co..

+2.01 (+3.71%)

USD47.08B 13.79 N/A
KKR KKR & Co. Inc

+1.48 (+2.00%)

USD44.64B 8.28 4.08
BK-PC The Bank of New York Mellon Co..

N/A

USD41.70B 5.38 N/A
STT State Street Corporation

+3.77 (+4.25%)

USD34.07B 13.06 N/A
AMP Ameriprise Financial Inc

+10.84 (+3.80%)

USD32.40B 15.49 N/A
STT-PG State Street Corporation

+0.07 (+0.25%)

USD21.29B 4.08 N/A

ETFs Containing BME

Symbol Name Weight Mer Price(Change) Market Cap

Market Performance

  Market Performance vs.
Industry/Classification (Asset Management)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.39% 14% F 24% F
Dividend Return 4.68% 40% F 73% C
Total Return 0.29% 12% F 30% F
Trailing 12 Months  
Capital Gain -2.84% 15% F 24% F
Dividend Return 5.18% 36% F 73% C
Total Return 2.34% 12% F 31% F
Trailing 5 Years  
Capital Gain 30.56% 85% B 54% F
Dividend Return 33.93% 52% F 88% B+
Total Return 64.49% 82% B- 65% D
Average Annual (5 Year Horizon)  
Capital Gain 8.51% 89% B+ 57% F
Dividend Return 6.18% 50% F 89% B+
Total Return 14.69% 88% B+ 66% D
Risk Return Profile  
Volatility (Standard Deviation) 9.26% 78% C+ 84% B
Risk Adjusted Return 158.69% 100% A+ 99% A+
Market Capitalization 0.59B 74% C 41% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Asset Management)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 5.43 77% C+ 89% B+
Price/Book Ratio 0.97 28% F 76% C
Price / Cash Flow Ratio -30.38 95% A 93% A
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 20.22% 75% C 77% C+
Return on Invested Capital N/A N/A N/A N/A N/A
Return on Assets -0.02% 4% F 17% F
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio 0.19 58% F 90% A-
Short Percent 0.04% 79% C+ 97% A+
Beta 0.77 42% F 71% C-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.